Skip to main content
Top
Published in: Trials 1/2014

Open Access 01-12-2014 | Methodology

Automated real-time text messaging as a means for rapidly identifying acute stroke patients for clinical trials

Authors: Kati Jegzentis, Tim Nowe, Peter Brunecker, Matthias Endres, Bernd Haferkorn, Christoph Ploner, Jens Steinbrink, Gerhard Jan Jungehulsing

Published in: Trials | Issue 1/2014

Login to get access

Abstract

Background

Recruiting stroke patients into acute treatment trials is challenging because of the urgency of clinical diagnosis, treatment, and trial inclusion. Automated alerts that identify emergency patients promptly may improve trial performance. The main purposes of this project were to develop an automated real-time text messaging system to immediately inform physicians of patients with suspected stroke and to test its feasibility in the emergency setting.

Methods

An electronic standardized stroke algorithm (SSA) was implemented in the clinical information system (CIS) and linked to a remote data capture system. Within 10 minutes following the documentation and storage of basic information to CIS, a text message was triggered for patients with suspected stroke and sent to a dedicated trial physician. Each text message provided anonymized information on the exact department and unit, date and time of admission, age, sex, and National Institute of Health Stroke Scale (NIHSS) of the patient. All necessary information needed to generate a text message was already available – routine processes in the emergency department were not affected by the automated real-time text messaging system. The system was tested for three 4-week periods. Feasibility was analyzed based on the number of patients correctly identified by the SSA and the door-to-message time.

Results

In total, 513 text messages were generated for patients with suspected stroke (median age 74 years (19–106); 50.3% female; median NIHSS 4 (0–41)), representing 96.6% of all cases. For 48.3% of these text messages, basic documentation was completed within less than 1 hour and a text message was sent within 60 minutes after patient admission.

Conclusions

The system proved to be stable in generating text messages using IT-based CIS to identify acute stroke trial patients. The system operated on information which is documented routinely and did not result in a higher workload. Delays between patient admission and the text message were caused by delayed completion of basic documentation. To use the automated real-time text messaging system to immediately identify emergency patients suitable for acute stroke trials, further development needs to focus on eliminating delays in documentation for the SSA in the emergency department.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kasner SE, Del Giudice A, Rosenberg S, Sheen M, Luciano JM, Cucchiara BL, Messe SR, Sansing LH, Baren JM: Who will participate in acute stroke trials?. Neurology. 2009, 72: 1682-1688.CrossRefPubMedPubMedCentral Kasner SE, Del Giudice A, Rosenberg S, Sheen M, Luciano JM, Cucchiara BL, Messe SR, Sansing LH, Baren JM: Who will participate in acute stroke trials?. Neurology. 2009, 72: 1682-1688.CrossRefPubMedPubMedCentral
2.
go back to reference Dani KA, McCormick MT, Muir KW: Brain lesion volume and capacity for consent in stroke trials: potential regulatory barriers to the use of surrogate markers. Stroke. 2008, 39: 2336-2340.CrossRefPubMed Dani KA, McCormick MT, Muir KW: Brain lesion volume and capacity for consent in stroke trials: potential regulatory barriers to the use of surrogate markers. Stroke. 2008, 39: 2336-2340.CrossRefPubMed
3.
go back to reference Embi PJ, Jain A, Clark J, Harris CM: Development of an electronic health record-based clinical trial alert system to enhance recruitment at the point of care. AMIA Annu Symp Proc. 2005, 2005: 231-235.PubMedCentral Embi PJ, Jain A, Clark J, Harris CM: Development of an electronic health record-based clinical trial alert system to enhance recruitment at the point of care. AMIA Annu Symp Proc. 2005, 2005: 231-235.PubMedCentral
4.
go back to reference Elkins JS, Khatabi T, Fung L, Rootenberg J, Johnston SC: Recruiting subjects for acute stroke trials: a meta-analysis. Stroke. 2006, 37: 123-128.CrossRefPubMed Elkins JS, Khatabi T, Fung L, Rootenberg J, Johnston SC: Recruiting subjects for acute stroke trials: a meta-analysis. Stroke. 2006, 37: 123-128.CrossRefPubMed
5.
go back to reference Campbell MK, Snowdon C, Francis D, Elbourne D, McDonald AM, Knight R, Entwistle V, Garcia J, Roberts I, Grant A: Recruitment to randomised trials: strategies for trial enrollment and participation study: the STEPS study. Health Technol Assess. 2007, 11 (48): iii-ix-105CrossRef Campbell MK, Snowdon C, Francis D, Elbourne D, McDonald AM, Knight R, Entwistle V, Garcia J, Roberts I, Grant A: Recruitment to randomised trials: strategies for trial enrollment and participation study: the STEPS study. Health Technol Assess. 2007, 11 (48): iii-ix-105CrossRef
6.
go back to reference DeVon HA, Patmon FL, Rosenfeld AG, Fennessy MM, Francis D: Implementing clinical research in the high acuity setting of the emergency department. J Emerg Nurs. 2013, 39: 6-12.CrossRefPubMed DeVon HA, Patmon FL, Rosenfeld AG, Fennessy MM, Francis D: Implementing clinical research in the high acuity setting of the emergency department. J Emerg Nurs. 2013, 39: 6-12.CrossRefPubMed
7.
go back to reference Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne MH, Hennerici M: Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European cooperative acute stroke study (ECASS). JAMA. 1995, 274: 1017-1025.CrossRefPubMed Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne MH, Hennerici M: Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European cooperative acute stroke study (ECASS). JAMA. 1995, 274: 1017-1025.CrossRefPubMed
8.
go back to reference Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F: Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial: prolyse in acute cerebral thromboembolism. JAMA. 1999, 282: 2003-2011.CrossRefPubMed Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F: Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial: prolyse in acute cerebral thromboembolism. JAMA. 1999, 282: 2003-2011.CrossRefPubMed
9.
go back to reference Sandercock P, Lindley R, Wardlaw J, Dennis M, Lewis S, Venables G, Kobayashi A, Czlonkowska A, Berge E, Slot KB, Murray V, Peeters A, Hankey G, Matz K, Brainin M, Ricci S, Celani MG, Righetti E, Cantisani T, Gubitz G, Phillips S, Arauz A, Prasad K, Correia M, Lyrer P, The IST-3 collaborative group: The third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke. Trials. 2008, 9: 37-CrossRefPubMedPubMedCentral Sandercock P, Lindley R, Wardlaw J, Dennis M, Lewis S, Venables G, Kobayashi A, Czlonkowska A, Berge E, Slot KB, Murray V, Peeters A, Hankey G, Matz K, Brainin M, Ricci S, Celani MG, Righetti E, Cantisani T, Gubitz G, Phillips S, Arauz A, Prasad K, Correia M, Lyrer P, The IST-3 collaborative group: The third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke. Trials. 2008, 9: 37-CrossRefPubMedPubMedCentral
10.
go back to reference Hacke W, Albers G, Al-Rawi Y, Bogousslavsky J, Davalos A, Eliasziw M, Fischer M, Furlan A, Kaste M, Lees KR, Soehngen M, Warach S, DIAS Study Group: The desmoteplase in acute ischemic stroke trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke. 2005, 36: 66-73.CrossRefPubMed Hacke W, Albers G, Al-Rawi Y, Bogousslavsky J, Davalos A, Eliasziw M, Fischer M, Furlan A, Kaste M, Lees KR, Soehngen M, Warach S, DIAS Study Group: The desmoteplase in acute ischemic stroke trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke. 2005, 36: 66-73.CrossRefPubMed
11.
go back to reference Furlan AJ, Eyding D, Albers GW, Al-Rawi Y, Lees KR, Rowley HA, Sachara C, Soehngen M, Warach S, Hacke W: Dose escalation of desmoteplase for acute ischemic stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke. 2006, 37: 1227-1231.CrossRefPubMed Furlan AJ, Eyding D, Albers GW, Al-Rawi Y, Lees KR, Rowley HA, Sachara C, Soehngen M, Warach S, Hacke W: Dose escalation of desmoteplase for acute ischemic stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke. 2006, 37: 1227-1231.CrossRefPubMed
12.
go back to reference Zinkstok SM, Vermeulen M, Stam J, de Haan RJ, Roos YB: Antiplatelet therapy in combination with rt-PA thrombolysis in ischemic stroke (ARTIS): rationale and design of a randomized controlled trial. Cerebrovasc Dis. 2010, 29: 79-81.CrossRefPubMed Zinkstok SM, Vermeulen M, Stam J, de Haan RJ, Roos YB: Antiplatelet therapy in combination with rt-PA thrombolysis in ischemic stroke (ARTIS): rationale and design of a randomized controlled trial. Cerebrovasc Dis. 2010, 29: 79-81.CrossRefPubMed
13.
go back to reference Thomalla G, Fiebach JB, Ostergaard L, Pedraza S, Thijs V, Nighoghossian N, Roy P, Muir KW, Ebinger M, Cheng B, Galinovic I, Cho TH, Puig J, Boutitie F, Simonsen CZ, Endres M, Fiehler J, Gerloff C, WAKE-UP investigators: A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP). Int J Stroke. 2014, 9 (6): 829-836.CrossRefPubMed Thomalla G, Fiebach JB, Ostergaard L, Pedraza S, Thijs V, Nighoghossian N, Roy P, Muir KW, Ebinger M, Cheng B, Galinovic I, Cho TH, Puig J, Boutitie F, Simonsen CZ, Endres M, Fiehler J, Gerloff C, WAKE-UP investigators: A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP). Int J Stroke. 2014, 9 (6): 829-836.CrossRefPubMed
14.
go back to reference Jakovljevic D, Salomaa V, Sivenius J, Tamminen M, Sarti C, Salmi K, Kaarsalo E, Narva V, Immonen-Raiha P, Torppa J, Tuomilehto J: Seasonal variation in the occurrence of stroke in a Finnish adult population: the FINMONICA stroke register: Finnish monitoring trends and determinants in cardiovascular disease. Stroke. 1996, 27: 1774-1779.CrossRefPubMed Jakovljevic D, Salomaa V, Sivenius J, Tamminen M, Sarti C, Salmi K, Kaarsalo E, Narva V, Immonen-Raiha P, Torppa J, Tuomilehto J: Seasonal variation in the occurrence of stroke in a Finnish adult population: the FINMONICA stroke register: Finnish monitoring trends and determinants in cardiovascular disease. Stroke. 1996, 27: 1774-1779.CrossRefPubMed
15.
go back to reference Butte AJ, Weinstein DA, Kohane IS: Enrolling patients into clinical trials faster using real time recruiting. Proc AMIA Symp. 2000, 111-115. Butte AJ, Weinstein DA, Kohane IS: Enrolling patients into clinical trials faster using real time recruiting. Proc AMIA Symp. 2000, 111-115.
16.
go back to reference Weiner DL, Butte AJ, Hibberd PL, Fleisher GR: Computerized recruiting for clinical trials in real time. Ann Emerg Med. 2003, 41: 242-246.CrossRefPubMed Weiner DL, Butte AJ, Hibberd PL, Fleisher GR: Computerized recruiting for clinical trials in real time. Ann Emerg Med. 2003, 41: 242-246.CrossRefPubMed
17.
go back to reference Marks L, Power E: Using technology to address recruitment issues in the clinical trial process. Trends Biotechnol. 2002, 20: 105-109.CrossRefPubMed Marks L, Power E: Using technology to address recruitment issues in the clinical trial process. Trends Biotechnol. 2002, 20: 105-109.CrossRefPubMed
18.
go back to reference Dugas M, Lange M, Berdel WE, Muller-Tidow C: Workflow to improve patient recruitment for clinical trials within hospital information systems – a case-study. Trials. 2008, 9: 2-CrossRefPubMedPubMedCentral Dugas M, Lange M, Berdel WE, Muller-Tidow C: Workflow to improve patient recruitment for clinical trials within hospital information systems – a case-study. Trials. 2008, 9: 2-CrossRefPubMedPubMedCentral
Metadata
Title
Automated real-time text messaging as a means for rapidly identifying acute stroke patients for clinical trials
Authors
Kati Jegzentis
Tim Nowe
Peter Brunecker
Matthias Endres
Bernd Haferkorn
Christoph Ploner
Jens Steinbrink
Gerhard Jan Jungehulsing
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Trials / Issue 1/2014
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/1745-6215-15-304

Other articles of this Issue 1/2014

Trials 1/2014 Go to the issue